Previous research (Min et al., 2011) has demonstrated that CEBPD promotes lymphangiogenesis and metastasis in lung cancer by regulating the HIF-1α/VEGF-C signaling pathway. The gene discussed is HIF1A; the disease is lung carcinoma.